Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bismuth

Showing results (211-220 of 516) with videos related to

Pageof 52
Sort By:
Transplantation Proceedings|October 1, 1987
Use of flexible triple-drug immunosuppressive therapy in liver transplantationJ Gugenheim, D Samuel, F Saliba, et al.
Transplantation Proceedings|June 1, 1988
Use of cyclosporine A in combination with low-dose corticosteroids and azathioprine in liver transplantationJ Gugenheim, D Samuel, F Saliba, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1992
[Pregnancy after hepatic transplantation. 17 pregnancies]Y Ville, H Fernandez, D Samuel, et al.
Transplantation Proceedings|December 5, 1998
Cytokine mRNA expression in the liver after administration of donor leukocytesY Sato, O Farges, D Buffello, et al.
Transplantation|October 1, 1992
The influence of the glycogen content of the donor liver on subsequent graft function and survival in rat liver transplantationR Adam, I Astarcioglu, M Gigou, et al.
Transplantation Proceedings|August 1, 1995
Nodular regenerative hyperplasia of the liver following orthotopic liver transplantationM Sebagh, O Farges, D Samuel, et al.
Transplantation Proceedings|February 1, 1995
FK 506 as treatment of late acute rejection in liver transplant patientsP Rucay, D Samuel, O Farges, et al.
Surgery Today|January 1, 1996
Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantationH Isozaki, O Farges, D Samuel, et al.
Transplantation Proceedings|December 5, 1998
Impact of 70% partial hepatectomy on administration of donor leukocytes in cardiac transplantation in ratsY Sato, O Farges, D Buffello, et al.
Presse Medicale (Paris, France : 1983)|May 25, 1996
[Intrahepatic portasystemic shunt as a salvage treatment of uncontrolled hemorrhage caused by rupture of esophageal varices in patients with liver cirrhosis]D Azoulay, D Castaing, P Ichai, et al.
Pageof 52

Showing results (211-220 of 516) with videos related to

Sort By:
Pageof 52
Transplantation Proceedings|October 1, 1987
Use of flexible triple-drug immunosuppressive therapy in liver transplantationJ Gugenheim, D Samuel, F Saliba, et al.
Transplantation Proceedings|June 1, 1988
Use of cyclosporine A in combination with low-dose corticosteroids and azathioprine in liver transplantationJ Gugenheim, D Samuel, F Saliba, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1992
[Pregnancy after hepatic transplantation. 17 pregnancies]Y Ville, H Fernandez, D Samuel, et al.
Transplantation Proceedings|December 5, 1998
Cytokine mRNA expression in the liver after administration of donor leukocytesY Sato, O Farges, D Buffello, et al.
Transplantation|October 1, 1992
The influence of the glycogen content of the donor liver on subsequent graft function and survival in rat liver transplantationR Adam, I Astarcioglu, M Gigou, et al.
Transplantation Proceedings|August 1, 1995
Nodular regenerative hyperplasia of the liver following orthotopic liver transplantationM Sebagh, O Farges, D Samuel, et al.
Transplantation Proceedings|February 1, 1995
FK 506 as treatment of late acute rejection in liver transplant patientsP Rucay, D Samuel, O Farges, et al.
Surgery Today|January 1, 1996
Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantationH Isozaki, O Farges, D Samuel, et al.
Transplantation Proceedings|December 5, 1998
Impact of 70% partial hepatectomy on administration of donor leukocytes in cardiac transplantation in ratsY Sato, O Farges, D Buffello, et al.
Presse Medicale (Paris, France : 1983)|May 25, 1996
[Intrahepatic portasystemic shunt as a salvage treatment of uncontrolled hemorrhage caused by rupture of esophageal varices in patients with liver cirrhosis]D Azoulay, D Castaing, P Ichai, et al.
Pageof 52